Mirae Asset Large & Midcap Fund is the largest fund in its category, with assets growing over five-fold to Rs 33,000 crore in the last five years. Witnessing a rare performance blip since the onset of 2022, the fund bounced back in the second half of 2023. It reached parity with its category peers while maintaining strong performance against the S&P BSE 500 index. Its impeccable performance track record is evident in its long-term performance graph, where it consistently outperforms its peers and the index by a good margin. Reasons for outperformance The fund's exposure to the Healthcare sector has been lucrative, particularly its holdings in Gland Pharma, which has shown signs of recovery after taking a beating due to supply chain headwinds and government restrictions on exports of Enoxaparin. Further, its re-entry into Lup
Buy, hold, or switch. Get the call.
How's my portfolio doing? What do I need to fix? Where should I invest next? Fund Advisor answers each one. The Advisor Note every Saturday. A live session with Dhirendra Kumar every second Saturday.
No commissions. No conflicts. Since 1991.
See Plans
Already a subscriber ?Log In
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
